Infection Clinical Trials in Cleveland, Ohio
19 recruitingCleveland, Ohio
Showing 1–19 of 19 trials
Recruiting
Phase 2
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled36 locationsNCT05719441
Recruiting
Not Applicable
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
Urinary Tract Infections
University Hospitals Cleveland Medical Center47 enrolled1 locationNCT06976125
Recruiting
Not Applicable
The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®
Necrotizing FascitisNecrotizing Soft Tissue Infection
Benjamin T. Miller50 enrolled1 locationNCT06857708
Recruiting
Not Applicable
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
Urinary Tract Infections
University Hospitals Cleveland Medical Center136 enrolled1 locationNCT06808451
Recruiting
Phase 3
A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)
Chronic Hepatitis D Infection
Mirum Pharmaceuticals, Inc.80 enrolled27 locationsNCT07298330
Recruiting
Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
Respiratory Syncytial Virus Infections
University of Alabama at Birmingham370 enrolled15 locationsNCT05026749
Recruiting
Phase 1Phase 2
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
Cystic Fibrosis LungRespiratory Infections, Recurrent, Chronic
Respirion Pharmaceuticals Pty Ltd72 enrolled22 locationsNCT06016088
Recruiting
Phase 3
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
Central Line Associated Blood Stream Infections (CLABSI)
CorMedix200 enrolled15 locationsNCT06822426
Recruiting
Persona Revision Knee System Outcomes
Knee OsteoarthritisInfectionArthroplasty Complications+1 more
Zimmer Biomet380 enrolled16 locationsNCT04821154
Recruiting
Early Phase 1
T Cell Therapy of Opportunistic Cytomegalovirus Infection
Hematopoietic Stem Cell TransplantCytomegalovirus InfectionsOpportunistic Infections
Mari Dallas20 enrolled1 locationNCT02982902
Recruiting
Phase 2
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
HPV InfectionCervical DysplasiaCIN 2/3+2 more
Frantz Viral Therapeutics, LLC78 enrolled7 locationsNCT04098744
Recruiting
CERAMENT G Device Registry
Chronic OsteomyelitisFracture Related Infection
BONESUPPORT AB100 enrolled3 locationsNCT06010433
Recruiting
Phase 2
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
Vulvar DiseasesHPV InfectionHigh Grade Intraepithelial Neoplasia+10 more
Frantz Viral Therapeutics, LLC27 enrolled5 locationsNCT06075264
Recruiting
Not Applicable
Efficacy of A Novel RinSe Device to Reduce Oral Bacteria in Intubated IntEnsive CaRe Patients: a Pilot Study
Mechanical Ventilation ComplicationOral Bacterial Infection
The Cleveland Clinic21 enrolled1 locationNCT06193512
Recruiting
Not Applicable
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
Hemolytic-Uremic SyndromeShiga Toxin-Producing Escherichia Coli (E. Coli) Infection
University of Calgary1,040 enrolled26 locationsNCT05219110
Recruiting
Phase 3
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT
Post Operative Surgical Site Infection
Major Extremity Trauma Research Consortium1,200 enrolled31 locationsNCT04678154
Recruiting
Observational PIC Destination Cohort
HIV-1-infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections30 enrolled4 locationsNCT05985642
Recruiting
Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
COVID-19Lower Respiratory Tract InfectionImmunocompromised+1 more
Ansun Biopharma, Inc.274 enrolled67 locationsNCT03808922
Recruiting
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal InfectionsPulmonary Invasive Aspergillosis
Arkansas Children's Hospital Research Institute400 enrolled33 locationsNCT03827694